The 340B Rebate Pilot Guide
Everything covered entities need to prepare for January 1, 2027, in eight short reads.
HRSA's Revised 340B Rebate Model Pilot, Explained
The basics: dates, how a rebate claim works, and the protections in the revised pilot.
ReadWhich Manufacturers and Drugs Are in the 340B Rebate Pilot
The 10 manufacturers and 21 drugs in the pilot, the negotiated drugs left out, and why the NDC-11 matters.
ReadHow the 340B Rebate Pilot Affects Hospitals, Health Centers and Rural Entities
How the same rules play out for hospitals, health centers and rural entities, with the questions each should settle now.
ReadWhy Contract Pharmacies and TPAs Matter More Under the Rebate Model
The nine steps every pilot claim now goes through, and what your TPA and contract pharmacies need to get right.
ReadBeacon, 340B ESP and Truzo: The Stack Covered Entities Need
Where claims data goes in 2027: Beacon, 340B ESP, Truzo, the MTF and the CMS repository, plus a Beacon registration checklist.
Read340B Contract Pharmacy After the Rebate Pilot
What stays the same and what changes for contract pharmacy pilot drugs: replenishment at WAC, two receivables, MFP settlement, whether pharmacies will keep filling, and Aventi's two pathways.
ReadSpecialty and Infusion 340B Under the Rebate Pilot
Medical claims, wasted units and specialty pharmacy data for oncology and infusion programs, and why the covered entity, not the pharmacy, submits to Beacon.
ReadSplit Billing, WAC Purchasing and Cash Flow Under the Rebate Model
Purchasing accounts, accumulators and cash flow for hospitals buying pilot drugs at WAC.
Read